Immunoglobulins for Intravenous Administration (IVIG)

VITAZ vzw·Sint-Niklaas, Belgium·EUR 12M·Expired · Jul 16, 2026·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

High valueStructured notice only

Titre original de l'avis

Belgium – Immunoglobulins – Immunoglobulinen voor intraveneuze toediening (IVIG)

60/100

Score d'opportunité

Needs reviewLow complexity

SuppliesFrameworkExpired

Pourquoi ce score ?

Opportunité

60 / 100

Complexité

30 / 100

Facteurs de risque

Minimum turnover requirement is given as placeholder €XXX; actual amount may be high, potentially excluding bidders.

Inconsistency in EU funding flag: structured data indicates EU-funded, XML notice states 'no EU funds'. This could affe...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Informations clés

Pouvoir adjudicateur: VITAZ vzw
Pays: Belgique
CPV: 33690000 - Various medicinal products +1 autres
Date limite: Jul 16, 2026
Valeur estimée: EUR 12M

Aperçu

Moderate opportunity

Faits clés

EUR 12M estimated value
Framework procurement
Supplies contract
1 lot
Duration 48 MONTH
Supply of intravenous immunoglobulins (IVIG) on an as-needed basis under a single-operator framework agreement.
Delivery to Sint-Niklaas, Belgium.

Afficher le résumé complet

Open procedure framework agreement for the supply of intravenous immunoglobulins (IVIG) to VITAZ vzw in Sint-Niklaas, Belgium. Single lot, award based 100% on price, duration 48 months, maximum framework value €12,000,000 EUR. Essential tender documents available but not analyzed; key selection criterion (minimum average annual turnover) includes a placeholder (€XXX). Deadline 16 July 2026.

Risques

Minimum turnover requirement is given as placeholder €XXX; actual amount may be high, potentially excluding bidders.

Inconsistency in EU funding flag: structured data indicates EU-funded, XML notice states 'no EU funds'. This could affe...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.